Entering the field of regenerative medicine, ACTT is here to support you.
Regenerative medicine is a rapidly emerging and highly promising field that combines biomedical science with engineering technologies to harness the regenerative and reparative potential of cells, tissues, or organs to treat diseases and injuries. It offers exciting possibilities and is expected to become a revolutionary approach for addressing many chronic conditions and the growing demand for organ transplants.
Research in regenerative medicine requires the support of a comprehensive industrial ecosystem. ACTT connects the upstream and downstream sectors essential for R&D in the field of regenerative medicine, offering a full range of services to support innovation and development.
ACTT, rooted in technological innovation, has successfully achieved public listing. With expertise in supply chain integration, the company has expanded into the field of regenerative medicine, offering comprehensive services throughout the entire process.
By establishing a high-standard GTP (Good Tissue Practice) laboratory within the National Biotechnology Park, we are advancing our capabilities in cutting-edge research and development.
ACTT has integrated the upstream and downstream sectors of the industry to establish the iCARM, fostering collaboration and innovation across the entire field.
ACTT offers comprehensive services ranging from exosome research to advanced testing, providing end-to-end solutions in the field of exosome-based therapies and diagnostics.
From purification, extraction, membrane removal, to detailed analysis, ACTT provides a complete suite of exosome characterization services.
We offer comprehensive exosome analysis services, including protein profiling and miRNA detection, to provide detailed insights into exosome composition and function.
We provide end-to-end services for various cell types, from extraction to functional activity analysis, ensuring a thorough evaluation at each step.
We offer a wide range of contract R&D services tailored to regenerative medicine, supporting customized solutions for innovation and development in the field.
We provide a variety of cell product development services, including cell culture and facility usage, all offered through project-based collaborations. Please feel free to contact us for further discussion.
ACTT Medical Research Services
Contact Person: Mr. Chang
Contact Email: james.chang@actt.co